LinkedIn Profile

Access Abbott Vascular historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:abbottvascular 62948 May 21st, 2019 12:00AM Evalve, Inc. [a wholly owned subsidiary of Abbott Vascular, Inc.] 733 72.00 Open Medical Devices May 21st, 2019 05:20PM May 21st, 2019 05:20PM Evalve was incorporated in 1999 to design, develop, manufacture and market innovative devices to enable percutaneous repair of cardiac valves. The company’s initial products are intended to reduce the risks, trauma and cost associated with current open, arrested heart surgical options. The company’s present development and clinical efforts are focused on mitral valve repair with the MitraClip® system. Evalve obtained CE mark approval in 2008 for the MitraClip® system, the world’s first percutaneous valve repair system. In October, 2009 Evalve, Inc. was acquired by Abbott Vascular, Inc. Visit us at www.abbottvascular.com for current information about the company. Open Interventional Cardiology US Abbott Vascular Pharmaceuticals & Biotechnology
private:abbottvascular 62948 Mar 18th, 2018 12:00AM Evalve, Inc. [a wholly owned subsidiary of Abbott Vascular, Inc.] 713 75.00 Open Medical Devices Mar 18th, 2018 05:41PM Mar 18th, 2018 05:41PM Open Abbott Vascular Pharmaceuticals & Biotechnology
private:abbottvascular 62948 Feb 17th, 2018 12:00AM Evalve, Inc. [a wholly owned subsidiary of Abbott Vascular, Inc.] 703 79.00 Open Medical Devices Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Evalve was incorporated in 1999 to design, develop, manufacture and market innovative devices to enable percutaneous repair of cardiac valves. The company’s initial products are intended to reduce the risks, trauma and cost associated with current open, arrested heart surgical options. The company’s present development and clinical efforts are focused on mitral valve repair with the MitraClip® system. Evalve obtained CE mark approval in 2008 for the MitraClip® system, the world’s first percutaneous valve repair system. In October, 2009 Evalve, Inc. was acquired by Abbott Vascular, Inc. Visit us at www.abbottvascular.com for current information about the company. Abbott Vascular Pharmaceuticals & Biotechnology
private:abbottvascular 62948 Feb 16th, 2018 12:00AM Evalve, Inc. [a wholly owned subsidiary of Abbott Vascular, Inc.] 703 79.00 Open Medical Devices Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Evalve was incorporated in 1999 to design, develop, manufacture and market innovative devices to enable percutaneous repair of cardiac valves. The company’s initial products are intended to reduce the risks, trauma and cost associated with current open, arrested heart surgical options. The company’s present development and clinical efforts are focused on mitral valve repair with the MitraClip® system. Evalve obtained CE mark approval in 2008 for the MitraClip® system, the world’s first percutaneous valve repair system. In October, 2009 Evalve, Inc. was acquired by Abbott Vascular, Inc. Visit us at www.abbottvascular.com for current information about the company. Abbott Vascular Pharmaceuticals & Biotechnology
private:abbottvascular 62948 Feb 15th, 2018 12:00AM Evalve, Inc. [a wholly owned subsidiary of Abbott Vascular, Inc.] 703 79.00 Open Medical Devices Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Evalve was incorporated in 1999 to design, develop, manufacture and market innovative devices to enable percutaneous repair of cardiac valves. The company’s initial products are intended to reduce the risks, trauma and cost associated with current open, arrested heart surgical options. The company’s present development and clinical efforts are focused on mitral valve repair with the MitraClip® system. Evalve obtained CE mark approval in 2008 for the MitraClip® system, the world’s first percutaneous valve repair system. In October, 2009 Evalve, Inc. was acquired by Abbott Vascular, Inc. Visit us at www.abbottvascular.com for current information about the company. Abbott Vascular Pharmaceuticals & Biotechnology
private:abbottvascular 62948 Feb 14th, 2018 12:00AM Evalve, Inc. [a wholly owned subsidiary of Abbott Vascular, Inc.] 703 79.00 Open Medical Devices Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Evalve was incorporated in 1999 to design, develop, manufacture and market innovative devices to enable percutaneous repair of cardiac valves. The company’s initial products are intended to reduce the risks, trauma and cost associated with current open, arrested heart surgical options. The company’s present development and clinical efforts are focused on mitral valve repair with the MitraClip® system. Evalve obtained CE mark approval in 2008 for the MitraClip® system, the world’s first percutaneous valve repair system. In October, 2009 Evalve, Inc. was acquired by Abbott Vascular, Inc. Visit us at www.abbottvascular.com for current information about the company. Abbott Vascular Pharmaceuticals & Biotechnology
private:abbottvascular 62948 Feb 13th, 2018 12:00AM Evalve, Inc. [a wholly owned subsidiary of Abbott Vascular, Inc.] 703 79.00 Open Medical Devices Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Evalve was incorporated in 1999 to design, develop, manufacture and market innovative devices to enable percutaneous repair of cardiac valves. The company’s initial products are intended to reduce the risks, trauma and cost associated with current open, arrested heart surgical options. The company’s present development and clinical efforts are focused on mitral valve repair with the MitraClip® system. Evalve obtained CE mark approval in 2008 for the MitraClip® system, the world’s first percutaneous valve repair system. In October, 2009 Evalve, Inc. was acquired by Abbott Vascular, Inc. Visit us at www.abbottvascular.com for current information about the company. Abbott Vascular Pharmaceuticals & Biotechnology
private:abbottvascular 62948 Feb 12th, 2018 12:00AM Evalve, Inc. [a wholly owned subsidiary of Abbott Vascular, Inc.] 703 79.00 Open Medical Devices Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Evalve was incorporated in 1999 to design, develop, manufacture and market innovative devices to enable percutaneous repair of cardiac valves. The company’s initial products are intended to reduce the risks, trauma and cost associated with current open, arrested heart surgical options. The company’s present development and clinical efforts are focused on mitral valve repair with the MitraClip® system. Evalve obtained CE mark approval in 2008 for the MitraClip® system, the world’s first percutaneous valve repair system. In October, 2009 Evalve, Inc. was acquired by Abbott Vascular, Inc. Visit us at www.abbottvascular.com for current information about the company. Abbott Vascular Pharmaceuticals & Biotechnology
private:abbottvascular 62948 Feb 11th, 2018 12:00AM Evalve, Inc. [a wholly owned subsidiary of Abbott Vascular, Inc.] 703 79.00 Open Medical Devices Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Evalve was incorporated in 1999 to design, develop, manufacture and market innovative devices to enable percutaneous repair of cardiac valves. The company’s initial products are intended to reduce the risks, trauma and cost associated with current open, arrested heart surgical options. The company’s present development and clinical efforts are focused on mitral valve repair with the MitraClip® system. Evalve obtained CE mark approval in 2008 for the MitraClip® system, the world’s first percutaneous valve repair system. In October, 2009 Evalve, Inc. was acquired by Abbott Vascular, Inc. Visit us at www.abbottvascular.com for current information about the company. Abbott Vascular Pharmaceuticals & Biotechnology
private:abbottvascular 62948 Feb 10th, 2018 12:00AM Evalve, Inc. [a wholly owned subsidiary of Abbott Vascular, Inc.] 703 79.00 Open Medical Devices Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Evalve was incorporated in 1999 to design, develop, manufacture and market innovative devices to enable percutaneous repair of cardiac valves. The company’s initial products are intended to reduce the risks, trauma and cost associated with current open, arrested heart surgical options. The company’s present development and clinical efforts are focused on mitral valve repair with the MitraClip® system. Evalve obtained CE mark approval in 2008 for the MitraClip® system, the world’s first percutaneous valve repair system. In October, 2009 Evalve, Inc. was acquired by Abbott Vascular, Inc. Visit us at www.abbottvascular.com for current information about the company. Abbott Vascular Pharmaceuticals & Biotechnology

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.